Clinical Trial Update: Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating different loading doses of ticagrelor for antiplatelet effect in non-ST-segment elevation acute coronary syndrome patients undergoing P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-segment Elevation Acute Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: General Hospital of Chinese Armed Police Forces | Conditions: Non ST Segment Elevation Acute Coronary Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2016-11-09